coronary heart disease
Conditions
Interventions
Routine statins combine with Evocumab:Routine statins combine with Evocumab
Routine statins:Routine statins
Sponsors
The Second Affiliated Hospital of Dalian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosis of coronary heart disease; 2. PCI guided by IVUS; 3. Aged 18-85; 4. Patients or their family members sign informed consent.
Exclusion criteria
Exclusion criteria: 1) Liver, kidney, heart failure, tumor, systemic infection, autoimmune diseases, etc.; 2) Surgical history within 1 month before onset; 3) The patient had vasculitis, was in the active stage and had erythrocyte sedimentation rate >30ml/h; 4) Those who take inflammatory suppressive drugs, immunosuppressive drugs or hormone drugs; 5) Abnormal white blood cell count by routine blood test; 6) Coagulation disorders for any reason 7) Female subjects who are pregnant, lactating or have positive pregnancy test; Or had a birth plan within 6 months of the end of the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent atheroma volume(PAV); | — |
Secondary
| Measure | Time frame |
|---|---|
| Total atheroma volume(TAV);MLA;NC ratio(NC%);VHTCFA; | — |
Countries
China
Contacts
Public ContactJiajie Mei
The Second Affiliated Hospital of Dalian Medical University
Outcome results
None listed